View in EDS

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

Saved in:
Bibliographic Details
Title: The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.
Authors: Baďurová K; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Kapustová V; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Kotulová J; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Brinsa V; GeneSpector s.r.o., Prague, Czech Republic.; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic., Piherová L; GeneSpector s.r.o., Prague, Czech Republic.; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic., Janoušek V; Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.; Biodviser Ltd, Oldham, Manchester, UK., Pohludka M; GeneSpector s.r.o., Prague, Czech Republic., Richtář M; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic., Jelínek T; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Hájek R; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Chyra Z; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Ševčíková T; Department of Hematooncology, University Hospital Ostrava, Dvořákova 7, 701 03, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic. tereza.sevcikova@osu.cz.
Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 475-494. Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-2000
DOI:10.1007/s40291-026-00836-7